Greenwich LifeSciences, Inc. (GLSI) insider trading

By person

8 insiders · 121 transactions

172×

Snehal Patel holds 172 times base salary in stock. $126.47M of shares against $735.08K in salary for 2025.

Salary from the company's own proxy. The shares are what Snehal Patel last reported holding, valued at $13.10, the price Common Stock was last bought or sold at on the open market here, on 29 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Snehal Patel

CEO and CFO

$7.27M (86)

—

+$7.27M

9,653,878

65.77%

$126.47M

+31.4%

Kenneth Hallock

Director

$484.00K (5)

—

+$484.00K

794,308

5.41%

$10.41M

+34.1%

Jaye Thompson

VP Clinical Reg Affairs

$164.78K (21)

—

+$164.78K

264,148

1.80%

$3.46M

+4.4%

Frank Joseph Daugherty

Chief Medical Officer

$81.32K (5)

—

+$81.32K

90,121

0.6140%

$1.18M

+6.9%

David McWilliams

Director

$28.61K (3)

—

+$28.61K

620,301

4.23%

$8.13M

+39.6%

Eric Rothe

Director

$10.80K (1)

—

+$10.80K

313,226

2.13%

$4.10M

+0.6%

Kinnary Patel

10% owner

—

1,329,590

9.06%

$17.42M

+10.8%

Pankaj Amrit Patel

10% owner

—

0.0000%

$0.00

−100.0%

Greenwich LifeSciences, Inc.

What the insiders did Net buying

By person